Session Details

S002 Dermatology Review: Skin Cancer, Surgical, and Cosmetic

Fri, Mar 19, 9:00 AM - 12:00 PM
3 CME Available Symposium

DESCRIPTION

Cosmetic portion: We compare strategies for a novel pain medication used before and after cosmetic procedures, evaluate lasers and other modalities for scars, explore CO2 laser treatment of deep perioral and periocular rhytids, and examine ultrasound for safety and complication management in aesthetic practice.

General dermatologic/oncologic/reconstructive portion: We discuss available genetic studies for cancer management, review surgical strategies for medically complex patients, identify updates to the NCCN guidelines, and identify optimal cases for dermal substitutes in post-Mohs patients.

LEARNING OBJECTIVES

1.

Compare and analyze different strategies for a novel new pain medication to be used pre- and post-cosmetic procedures.

2.

Evaluate and optimize the use of lasers for scars and deep facial rhytids. Examine the use of ultrasound in the aesthetic practice.

3.

Discuss available genetic studies for cancer management. Define strategies in surgical management of medically complex patients. Identify updates to the NCCN guidelines. Identify uses for dermal substitutes.

SCHEDULE

9:00 AM

Introduction

Naomi Lawrence, MD, FAAD

9:05 AM

Build a non-opioid, multimodal pain plan for office surgery and cosmetic procedures, including where suzetrigine (Journavx) fits, topical pain control, vibration

Anne M. Chapas, MD, FAAD

9:20 AM

Build a non-opioid, multimodal pain plan for office surgery and cosmetic procedures, including where suzetrigine (Journavx) fits, topical pain control, vibration | Discussion

9:35 AM

Ultrasound in Aesthetic Injectables: Applications for Safety and Complication Management

Hooman Khorasani, MD, FAAD

9:50 AM

Multimodal treatment of scars

10:05 AM

Optimizing Co2 laser for perioral and periocular rhytids

Kimberly J. Butterwick, MD, FAAD

10:20 AM

Cosmetic Discussion

Naomi Lawrence, MD, FAAD, Kimberly J. Butterwick, MD, FAAD, Hooman Khorasani, MD, FAAD

10:30 AM

Use of dermal substitutes in dermatologic surgery (ie. Integra, BTM)

Tara S. Jennings, MD

10:45 AM

Updates of NCCN guidelines

Kathryn Shahwan, MD, FAAD

11:00 AM

Surgical management of medically complex patients

Pooja Rambhia, MD, FAAD

11:15 AM

Genetic studies useful in CA management

Bryan T. Carroll, MD, PhD, FAAD

11:30 AM

Dermatologic Surgery Discussion

Naomi Lawrence, MD, FAAD, Bryan T. Carroll, MD, PhD, FAAD, Tara S. Jennings, MD, Pooja Rambhia, MD, FAAD, Kathryn Shahwan, MD, FAAD

DIRECTOR

Naomi Lawrence, MD, FAAD

Naomi Lawrence, MD, FAAD

Cooper Hospital Rowan University

SPEAKERS

Kimberly J. Butterwick, MD, FAAD

Kimberly J. Butterwick, MD, FAAD

Bryan T. Carroll, MD, PhD, FAAD

Bryan T. Carroll, MD, PhD, FAAD

Anne M. Chapas, MD, FAAD

Anne M. Chapas, MD, FAAD

Tara S. Jennings, MD

Tara S. Jennings, MD

Pooja Rambhia, MD, FAAD

Pooja Rambhia, MD, FAAD

Cooper University Health care

Kathryn Shahwan, MD, FAAD

Kathryn Shahwan, MD, FAAD

DISCLOSURES

Kimberly J. Butterwick, MD, FAAD

Allergan, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Evolus, Inc. – Advisory Board(Honoraria); Galderma – Advisory Board(Honoraria); Merz Pharmaceuticals, LLC – Advisory Board(Honoraria); Neutrogena Corporation – Advisory Board(Honoraria); Rapalogix Health – Stockholder Private Company(Stock); Revance Therapeutics, Inc. – Advisory Board(Honoraria);

Bryan T. Carroll, MD, PhD, FAAD

No financial relationships exist with ineligible companies.

Anne M. Chapas, MD, FAAD

Allergan, Inc – Speaker/Faculty Education(Honoraria); Cutera – Advisory Board(Fees); Cytrellis Biosystems, Inc – Speaker(Honoraria); Evolus, Inc. – Speaker(Honoraria); Galderma – Advisory Board(Fees); InMode MD Ltd – Investigator(Grants/Research Funding); Lumenis – Investigator(Grants/Research Funding); lutronic – Speaker(Honoraria); Revance – Investigator(Grants/Research Funding); reveance – Investigator(Grants/Research Funding); Rion Aesthetics – Investigator(Grants/Research Funding); sofwave – Speaker(Honoraria); Solta Medical – Speaker(Honoraria); Syneron Candela – Advisory Board(Honoraria);

Tara S. Jennings, MD

No financial relationships exist with ineligible companies.

Naomi Lawrence, MD, FAAD

No financial relationships exist with ineligible companies.

Pooja Rambhia, MD, FAAD

No financial relationships exist with ineligible companies.

Kathryn Shahwan, MD, FAAD

Highlight Therapeutics – Advisory Board(Honoraria); Sun Pharmaceutical – Advisory Board(Honoraria);